SCHEMBL13556865

SCHEMBL13556865

c1ccc2c(c1)cc(-n1c3ccncc3c3c4ccccc4c4c(c5ccccc5c5c6cnccc6n(-c6cc7ccccc7c7ccccc67)c54)c31)c1ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ RAD52 P43351 1/20 0.41
▸ CYP11B1 P15538 2/20 0.40
▸ TOP2A P11388 1/20 0.40
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ CYP1A2 P05177 3/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MAOA P21397 5/20 0.35
▸ MAOB P27338 4/20 0.35
▸ ACHE P22303 2/20 0.35
▸ CLK1 P49759 1/20 0.32
▸ CLK2 P49760 1/20 0.32
▸ CLK3 P49761 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627494 0.84 CYP1A2 (0.42) KDM4EPOLBRAD52TOP2ACYP1A2
SCHEMBL13556860 0.83 NPC1 (0.40) KDM4ETOP2ACYP1A2MAOAMAOB
SCHEMBL20312026 0.80 CYP1A2 (0.40) KDM4ECYP1A2CYP2C9CYP2C19MAOA
SCHEMBL14330538 0.79 MAOA (0.44) KDM4EHTTPOLBRAD52CYP11B1
SCHEMBL13556864 0.78 MAOA (0.40) KDM4ETOP2ACYP1A2CYP2C9MAOA
SCHEMBL13556863 0.78 KDM4E (0.44) KDM4ETOP2ACYP1A2MAOAMAOB
SCHEMBL15436330 0.77 TOP2A (0.39) KDM4EHTTPOLBRAD52CYP11B1
SCHEMBL24768817 0.75 CYP1A2 (0.39) TOP2ACYP1A2CYP2C9CYP2C19
SCHEMBL13556840 0.75 ALDH1A1 (0.38) KDM4EHTTCYP11B1CYP1A2CYP2C9
SCHEMBL19046747 0.75 CYP1A2 (0.41) KDM4EPOLBRAD52CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889270-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2014-11-18 — — US disclosed
US-8889270-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2014-11-18 — — US disclosed
US-20120267613-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-25 — — US disclosed
US-20120267613-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120267613-A1 ORGANIC LIGHT-EMITTING DEVICE CRY1, CYP1A1, CRY2 KDM4E 3048/4885HTT 1899/4885POLB 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback